ADC Biotransformation Monitoring


SMART Digest IA Streptavidin beads (
Part no. 60110-104)

  • Antibody-drug conjugates (ADCs) are a promising class of therapeutics

  • Assessment of what happens to these molecules in-vivo is a key part of development

  • Specifically, assessing the biotransformation of ADCs is key to understanding their stability and pharmacokinetic properties

  • The presented method provides a detailed structural analysis of biotransformation products

 Example protocol

  • 4ug biotinylated anti-idiotype antibodies added to 30uL of SMART Digest IA Streptavidin beads (Part no. 60110-104)

  • Immuno-capture performed by incubating 50 µL human plasma and 30 µL of previously prepared SMART IA beads at 37°C with constant shaking for 2 h.

  • After incubation, the bead mixture is washed multiple times.

  • SMART Digest buffer and internal standards spiked added to each well

  • Sample digested 70°C for 2 h with constant shaking.

  • After digestion, 4/5 of the sample volume is cleaned up and concentrated by reversed phase SPE

  • (Optional) The remaining 1/5 of the sample volume is incubated overnight at room temperature with papain to release the conjugated payload. Papain digest cleaned up and concentrated by reversed phase SPE

Select Publications